Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.396,62
-0,54%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ QuidelOrtho Corporation (QDEL) QuidelOrtho Corporation (QDEL) Notizie

QuidelOrtho Corporation

QDEL
39,64
-0,05 (-0,13%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202411:45PRNUSQuidelOrtho Corporation f/k/a Quidel Corporation Sued for..
19/4/202412:40PRNUSClass Action Filed Against QuidelOrtho Corporation f/k/a..
17/4/202413:00BWQuidelOrtho To Report First Quarter 2024 Financial Results
10/4/202413:00BWQuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a..
02/4/202415:00BWQuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue®..
06/3/202422:35BWQuidelOrtho Receives Health Canada Approval for Quidel®..
29/2/202422:40EDGAR2Form 8-K/A - Current report: [Amend]
29/2/202421:29EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202422:30BWQuidelOrtho to Participate in 45th Annual Raymond James..
21/2/202413:30EDGAR2Form 8-K - Current report
21/2/202413:30BWQuidelOrtho Announces Changes in Executive Leadership
16/2/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202413:00EDGAR2Form 8-K - Current report
13/2/202422:07EDGAR2Form 8-K - Current report
13/2/202422:05BWQuidelOrtho Reports Fourth Quarter and Full-Year 2023..
13/2/202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202413:00BWQuidelOrtho to Report Fourth Quarter and Full-year 2023..
22/12/202313:00BWQuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare..
20/12/202322:05BWQuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex..
08/12/202322:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/12/202322:40EDGAR2Form 8-K - Current report
16/11/202323:05BWQuidelOrtho to Participate in the Evercore ISI Conference
01/11/202321:12EDGAR2Form 8-K - Current report
01/11/202321:05BWQuidelOrtho Reports Third Quarter 2023 Financial Results
17/10/202321:43PRNUSPowerful Lyme Disease Awareness PSA Featuring Christopher..
12/10/202313:04EDGAR2Form 8-K - Current report
12/10/202313:00BWQuidelOrtho Reports Preliminary Revenue Results for the..
21/9/202322:05BWQuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+..
28/8/202322:05BWQuidelOrtho to Participate in the Morgan Stanley 21st Annual..
18/8/202322:06EDGAR2Form 8-K - Current report
08/8/202323:00EDGAR2Form 8-K - Current report
08/8/202322:30BWQuidelOrtho Reports Second Quarter 2023 Financial Results
25/7/202322:00BWQuidelOrtho Ranks No. 1 in Customer Satisfaction for Six..
25/7/202319:12BWQuidelOrtho Partners With BYG4lab® to Strengthen Informatics..
24/7/202321:00BWQuidelOrtho Partners With BYG4lab® to Strengthen Informatics..
18/7/202322:05BWQuidelOrtho to Report Second Quarter 2023 Financial Results
23/5/202313:00BWQuidelOrtho to Participate in William Blair 43rd Annual..
03/5/202322:05BWQuidelOrtho Reports First Quarter 2023 Financial Results
Apertura: 39,49 Min: 39,30 Max: 40,405
Chiusura: 39,69

La tua Cronologia

NASDAQ
QDEL
QuidelOrtho
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network